Financial Statements

Merck & Co., Inc. (MRK)


+2.13 (+2.03%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands

Retained Earning Schedule

Year 2022 2021 2020 2019 2018
Retained Earnings (Previous Year) 53,69647,36246,60242,579-
Net Income 14,51913,0497,0679,8436,220
Stock Dividends -122-105-92-12541,531
Dividend Paid -7,012-6,610-6,215-5,695-5,172
Retained Earnings 61,08153,69647,36246,60242,579

PPE Schedule

Year 2022 2021 2020 2019 2018
Gross PPE 19,27917,98615,05313,291-
Annual Depreciation 6,5315,7417,6175,23515,906
Capital Expenditure -4,388-4,448-4,684-3,473-2,615
Net PPE 21,42219,27917,98615,05313,291

Intangible and Goodwill Schedule

Year 2022 2021 2020 2019 2018
Intangible and Goodwill (Previous Year) -18,25319,42520,23821,264
New Purchases -7,994-3,202-1,095-1-1,204
Intangible and Goodwill 18,25319,42520,23821,26421,204

Merck & Co., Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Merck & Co., Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.